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Correspondence jshorter@pennmedicine.upenn.edu (J.S.) , nbonini@sas.upenn.edu (N.M.B.) In Brief McGurk et al. show that TDP-43 is a PARbinding protein and that this function stimulates liquid-liquid phase separation and stress granule localization. Under short-term stress, the stress granule protects TDP-43 from phosphorylation. TDP-43 foci that persist during long-term stress transition into the phosphorylated state. Inhibition of the PARP Tankyrase mitigates both the cytoplasmic accumulation of TDP-43 and neuronal degeneration.
INTRODUCTION
In almost all cases of amyotrophic lateral sclerosis (ALS) and $50% of frontotemporal degeneration (FTD), the normally nuclear RNA-binding protein transactive response (TAR) DNA binding protein of 43 kDa (TDP-43) forms phosphorylated aggregates in the cytoplasm of affected neurons and glia (Hasegawa et al., 2008; Mackenzie et al., 2007; Neumann et al., 2006) . Increasing evidence suggests that stress pathways are central to ALS and FTD, collectively known as ALS/FTD. For example, TDP-43, along with other RNA-binding proteins associated with ALS/ FTD, including FUS, Ataxin 2, TIA-1, and hnRNPA1, are components of stress granules (Li et al., 2013) . Stress granules are cytoplasmic membraneless organelles that sequester RNA-protein complexes involved in the initiation of protein translation (Kedersha et al., 1999) . In post-mortem tissue, phosphorylated TDP-43 congregates with the stress granule proteins eIF3, TIA-1, and PABPC-1 (Bentmann et al., 2012; Liu-Yesucevitz et al., 2010; McGurk et al., 2014) . In cellular and animal models of ALS and FTD, stress granule biogenesis may also contribute to the degenerative process because downregulation of the stress granule proteins Ataxin-2 and poly(A)-binding protein (PABP) mitigates disease-associated toxicity (Becker et al., 2017; Elden et al., 2010; Kim et al., 2014; Zhang et al., 2018) . Although mounting pathological and genetic evidence implicates stress pathways in ALS and FTD, how stress contributes to disease and to TDP-43-associated pathology remains enigmatic.
Stress granule assembly occurs via condensation of localized RNA-protein complexes into dynamic liquid droplets-a process called liquid-liquid phase separation (LLPS) (Hyman et al., 2014; Wippich et al., 2013) . A remarkable feature of proteins that localize to stress granules is that they can undergo spontaneous LLPS in vitro (Lin et al., 2015; Mackenzie et al., 2017; Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015) . Protein domains important for LLPS tend to be intrinsically disordered regions, including the prion-like domains (PrLDs) of the ALSassociated proteins hnRNPA1, FUS, TIA1, and TDP-43, which drive LLPS as well as the formation of solid gel-like structures (Conicella et al., 2016; Han et al., 2012; Kato et al., 2012; Lin et al., 2015; Mackenzie et al., 2017; Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015; Ryan et al., 2018; Sun et al., 2011; Xiang et al., 2015) . Although TDP-43 has been shown to phase-separate, it is unknown how LLPS of TDP-43 is regulated in health and disease. Thus, uncovering the regulatory mechanisms that link LLPS, stress granule assembly, and abnormal protein accumulation could illuminate important pathways relevant to disease.
A regulator of protein localization and liquid demixing in the cellular milieu is poly(ADP-ribose) (PAR) (Krietsch et al., 2013; Leung, 2014) . PAR is a negatively charged biopolymer that is covalently attached to target proteins by PAR polymerases (PARPs) (Gibson and Kraus, 2012) . The PAR polymer is recognized by ''reader'' proteins, and, in this way, PAR reading drives the assembly of protein complexes (Krietsch et al., 2013; Teloni and Altmeyer, 2016) . PARP activity regulates a plethora of cellular processes (Caldecott, 2014; Fatokun et al., 2014; Hottiger, 2015; Hsiao and Smith, 2008) , including stress granule assembly (Catara et al., 2017; Isabelle et al., 2012; Leung et al., 2011 ). Here we demonstrate that reduction of the PARP tankyrase inhibits TDP-43-associated neurodegeneration in vivo. We show that Tankyrase-1/2 regulates the formation of stressinduced cytoplasmic TDP-43 foci in mammalian cells and that PAR binding to TDP-43 regulates stress granule recruitment. These studies provide insight into the liquid demixing of TDP-43 and suggest that small-molecule inhibitors of Tankyrase could be developed as therapeutic agents for ALS/FTD.
RESULTS

Tankyrase Modulates TDP-43-Associated Toxicity in Drosophila
To identify novel pathways relevant to TDP-43-associated toxicity, we initiated a genetic modifier screen in the fly. Selective expression of the human TDP-43 protein in the fly eye using the glass multiple repeat-GAL4 (gmr-GAL4) driver leads to external and internal degeneration (Figure 1A ). In the screen, we discovered that downregulation of tankyrase (Tnks, CG4719), a PARP (Smith et al., 1998) , significantly reduced degeneration of the eye ( Figures 1A-1D ). We confirmed that expression of the inverted repeat reduced Tnks mRNA levels (0.5 ± 0.1 fold ± SEM of normal levels) (Figure S1A ) and that reduced Tnks had no effect on total TDP-43 protein levels or the levels of a control protein (b-galactosidase) (Figures S1B and S1C), indicating that downregulation of Tnks did not affect the GAL4 expression system. Additionally, reduction of Tnks had no effect on the Alzheimer's disease-and FTD-associated protein Tau (Figure S1D) ; thus, the interaction was selective for TDP-43-associated degeneration. Finally, upregulation of Tnks enhanced TDP-43-associated toxicity in the eye without having an effect on the eye morphology on its own (Figure S1E) or on the GAL4 expression system (Figure S1F ). Together, these data implicate Tnks as a novel dose-sensitive regulator of TDP-43-associated degeneration.
We extended these studies to the fly CNS. Neuronal expression of TDP-43 with the elav-GAL4 driver resulted in early death (Figure 1E ). Downregulation of Tnks significantly restored the lifespan defects of the TDP-43 flies while having no effect on the lifespan of controls (Figure 1E; Figures S1G and S1H) . Downregulation of Tnks in the nervous system had no effect on the total protein levels of . However, lowered Tnks levels led to a significant increase in nuclear TDP-43 (1.9 ± 0.1 [SEM] ) and a significant decrease in cytoplasmic TDP-43 (0.6 ± 0.1 [SEM] ) compared with the control (Figures 1F and 1G and S1I and S1J) . Taken together, these data indicate that the downregulation of Tnks in the nervous system correlates with increased nuclear TDP-43 and mitigates TDP-43-induced degeneration of the nervous system. TDP-43 Binds to PAR via the Nuclear Localization Sequence A previous proteomics screen identified TDP-43 as one of many proteins that co-immunoprecipitated with a PAR glycohydrolase (PARG) (Gagné et al., 2012) , suggesting that TDP-43 could be a PAR-binding protein. Given that Tnks genetically interacted with TDP-43 in the fly, we determined whether TDP-43 and PAR may associate in the same protein complex. Human TDP-43 was expressed in the fly nervous system, and, under non-denaturing conditions, we observed PAR to co-immunoprecipitate with TDP-43 from fly protein lysate (Figure 2A ). Furthermore, PAR and endogenous TDP-43 co-immunoprecipitated from mammalian cells (Figures 2B and 2C) . These data indicate that TDP-43 and PAR can co-exist in the same protein complex in fly and mammalian protein lysates and raise the possibility that TDP-43 non-covalently interacts with PAR.
To ascertain whether TDP-43 could bind to PAR, we performed a PAR-binding dot blot. Wild-type (WT) TDP-43 (glutathione S-transferase [GST]-TDP-43-WT) was spotted onto a membrane with a canonical PAR-binding protein, histone H4 (Panzeter et al., 1993) , and a GST-negative control. Incubation with PAR polymer followed by immunoblotting with an antibody directed to PAR revealed that both histone H4 and TDP-43 bound to PAR ( Figure 2D ). The most common PAR-binding module is the PAR-binding motif (PBM) (Teloni and Altmeyer, 2016 Gagné et al., 2008) to TDP-43 revealed that the region with the highest similarity (80%) was in the nuclear localization sequence (NLS) ( Figures 2E and S2A) ; a second site with lower similarity (63%) was also identified within the NLS ( Figures 2E and S2A ). TDP-43 has a bipartite NLS typified by two clusters of basic amino acids, mutation of which leads to cytoplasmic accumulation of TDP-43 (Winton et al., 2008) . Curiously, it was these clusters of basic residues that aligned to the PBM. Here we refer to these two regions as PBM1 and PBM2 (Figure 2E) . These data raised the intriguing possibility that the NLS of TDP-43 may be involved in binding to PAR. To verify this possibility, we performed PAR-binding dot blots on peptides that span PBM1 or PBM2 ( Figures 2F and 2G ). This revealed that PAR bound to the peptide corresponding to PBM2 of TDP-43 ( Figure 2G ) and not to the peptide corresponding to PBM1 (Figure 2G) . These data suggest that the NLS and PBM2 of TDP-43 is a region capable of binding to PAR.
We next determined whether mutation of the PBMs in the fulllength TDP-43 protein altered PAR binding and substituted the key lysine and arginine residues with alanine in PBM1, PBM2, or both (DPBM). Mutation of PBM1, PBM2, or both led to a significant reduction in PAR binding to TDP-43 (0.23 ± 0.08-fold, 0.11 ± 0.04-fold, and 0.09 ± 0.03-fold ± SEM, respectively, of WT levels) (Figures 2H and 2I) . These data indicate that although the PBM2 peptide, but not the PBM1 peptide, can directly bind to PAR, mutation of either PBM is sufficient to diminish the capacity of the full-length protein to bind to PAR. Taken together, these data implicate TDP-43 as a PAR-binding protein and establish the NLS as a region that mediates this interaction.
PAR Promotes LLPS of TDP-43
PAR seeds protein localization and liquid demixing in vivo (Leung, 2014; Teloni and Altmeyer, 2016) . Liquid demixing is also an in vitro characteristic of proteins associated with ALS (Harrison and Shorter, 2017) . Thus, we assessed whether TDP-43 could undergo liquid demixing (LLPS) in vitro and whether and has no effect on its own (Tnks.IR). (B) Reduction of Tnks improved the external eye of TDP-43 flies. Mean (± SEM), n = 3, and two-way ANOVA (p < 0.0001). (C) Reduction of Tnks reduced vacuolization of the TDP-43 retina. Mean (± SEM), n = 3, one-way ANOVA (p < 0.0001), and Tukey's test. Asterisks, significant; NS, not significant. (D) Reduction of Tnks increased the retinal width of TDP-43 flies. Mean (± SEM), n = 3, one-way ANOVA (p < 0.0001), and Tukey's test. Asterisks, significant. (E) Reduction of Tnks (Tnks.IR) mitigated the lifespan defect of flies expressing TDP-43 in the brain. More than 190 male flies were followed per genotype. Log rank test for trend, p < 0.0001. (F) Reduction of Tnks (Tnks.IR) had no effect on total TDP-43 levels but increased nuclear and decreased cytoplasmic TDP-43. (G) TDP-43 protein levels relative to control protein (F) . Mean (± SEM), one-way ANOVA (p < 0.001), and Tukey's test. Asterisks, significant. **p < 0.01, ***p < 0.001, and ****p < 0.0001. Genotypes are as follows:
IR is UAS-Tnks.IR/+; gmr -GAL4 (III)/+. TDP-43 + ctrl is UAS-TDP-43(M)/UAS-mCD8-GFP; gmr-GAL4 (III)/+ and TDP-43+Tnks-IR is UAS-TDP-43 (M)/UAS-Tnks-IR 4179R-4 ; gmr-GAL4 (III)/+.
In ( The presence (green) or absence (red) of protein droplets is plotted, and the gray area indicates the phase boundary. The results were confirmed in two independent protein preparations. Conditions at the phase boundary (gray side) were repeated three times. (E) Addition of PAR (1-5 mM mono(ADP-ribose) equivalents) promoted TDP-43-WT LLPS in a dose-dependent manner. This was performed on one protein preparation. (F) The presence (green) or absence (red) of TDP-43 droplets. (G) PAR promoted 5 mM TDP-43-WT LLPS in 50 mM NaCl. Heparin, yeast total RNA, and mono(ADP-ribose) (MAR) at the same concentration had no effect. The experiment was repeated twice from 1 protein preparation. All experiments were performed at room temperature. See also Figure S2 .
by increasing the salt (NaCl) concentration ( Figure 3C ). Thus, LLPS of full-length TDP-43 can be achieved under physiological conditions and is dependent on TDP-43 and salt concentrations. To evaluate whether PAR could promote LLPS of TDP-43, we lowered the concentration of TDP-43 to 1 mM and the salt concentration to 100 mM; under these conditions, TDP-43 did not undergo LLPS ( Figure 3C ). The addition of PAR (1-5 mM ADPribose equivalents) at a chain length ranging from 2-300 ADPribose subunits stimulated TDP-43 LLPS in a dose-dependent manner ( Figures 3D-3F ). At lower protein and salt concentrations, 5 mM PAR promoted LLPS of TDP-43 (Figure 3D and S2E) and lowered the phase boundary. By contrast, addition of heparin, total RNA, mono(ADP-ribose), or BSA did not stimulate TDP-43 LLPS, and PAR did not undergo LLPS in the absence of protein ( Figures 3G and S2F-S2J ). Finally, we purified TDP-43 as a C-terminally tagged MBP fusion protein (TDP-43-WT-MBPHis 6 ) ( Figure S2C ). Under physiological salt conditions (150 mM NaCl) and with dextran, TDP-43-WT-MBP spontaneously formed liquid droplets (Figure S2K) , and the addition of PAR to TDP-43-WT-MBP promoted LLPS ( Figure S2L ). Thus, PAR-mediated LLPS of TDP-43 is a feature of TDP-43 and is independent of the protein tag.
We next asked whether PAR-regulated LLPS of TDP-43 required the PAR-binding motifs in the NLS (Figure 2 ). Under conditions in which TDP-43 phase-separated, TDP-43 with mutation in both PAR-binding motifs (His 6 -SUMO-TDP-43-DPBM) (Figure S2B) formed irregular structures that were smaller in size and did not fuse, indicating an aberrant phase transition to solid-like states ( Figures 4B and 4C) . At a lower salt concentration (50 mM NaCl), TDP-43-DPBM remained diffuse, indicating that transition into a solid state is salt-dependent ( Figure 4C ). In support of our conclusion that the NLS harbors functional PAR-binding motifs, the addition of PAR failed to promote LLPS of TDP-43-DPBM (Figures 4D and 4E ; Figure S2M ). Thus, the PAR-binding motifs are critical for normal LLPS of TDP-43.
Disease-Associated TDP-43 Has Altered LLPS Dynamics In disease, TDP-43 can become N-terminally truncated (Igaz et al., 2009; Neumann et al., 2006 Neumann et al., , 2009 , raising the possibility that fragments of TDP-43 that accumulate in disease may have impaired LLPS properties. To assess this, we examined a 35-kDa isoform of TDP-43 identified in ALS spinal cord tissue (Xiao et al., 2015) and a 25-kDa fragment of TDP-43 identified in ALS brain tissue (Kametani et al., 2016) . The fragments were purified as His 6 -SUMO-tagged fusion proteins (His 6 -SUMO-TDP-43-C35 and His 6 -SUMO-TDP-43-C25) (Figures 4A and S2B) . Under conditions where TDP-43-WT phase-separated, TDP-43-C35, which retains PBM2, formed small, spherical structures that did not fuse, whereas the C25 fragment formed filamentous aggregates ( Figures 4B and 4C ), indicating that they both lacked liquid properties. Moreover, PAR was ineffective at promoting LLPS of TDP-43-C35 or TDP-43-C25 at all salt and protein concentrations tested (Figures 4D and 4E ; Figure S2M ). Collectively, these advances highlight that the N-terminal region and the PBMs are critical for TDP-43 liquid demixing.
To assess the effect of an ALS-linked mutation on PAR-stimulated LLPS of TDP-43, we expressed and purified TDP-43 with an ALS-linked mutation, Q331K (His 6 -SUMO-TDP-43-Q331K) ( Figure S2D ), previously shown to promote aggregation (Johnson et al., 2009) . Surprisingly, the Q331K mutation did not completely prevent TDP-43 from forming protein droplets (Figures 4B and 4C) ; however, the droplets were fewer in number, and, at lower NaCl concentrations, the droplets coexisted with irregular solid structures (Figures 4B and 4C and S2M and S2N) . At low NaCl concentrations, PAR promoted the aggregation of solid irregular structures of TDP-43-Q331K (Figures 4D and 4E) and was ineffective at higher salt concentrations (Figure S2M) . Together, these data suggest that the Q331K mutation is defective in LLPS and that the propensity to aggregate can be stimulated by PAR.
The PBMs Are Required for TDP-43 Stress Granule Localization We extended these findings to the intracellular milieu of mammalian cells. Under normal conditions, PAR levels are low, and TDP-43 is predominantly nuclear; however, upon stress, PAR and TDP-43 form foci in the cytoplasm ( Figures S3A-S3C ). PAR is a constituent of mammalian stress granules (Catara et al., 2017; Leung et al., 2011) ; hence, we co-labeled the cells with the stress granule markers eIF3, T-cell-restricted intracellular antigen 1 (TIA-1)-related protein (TIAR), Ataxin-2, and PAR ( Figures  S3B-S3E ) to reveal that TDP-43 and PAR coexist in stress granules (Figures 2A-S2C ). To ascertain whether the PBMs in the NLS regulated TDP-43 localization to PAR-containing stress granules, we expressed TDP-43-YFP and immunostained for PAR. This revealed that mutation of the PBM reduced PAR labeling of TDP-43-YFP from 93% ± 2% to 17.6% ± 4.9% (SEM) ( Figures  S3F-S3H ). These data indicate that mutation in the PBM reduces the ability of TDP-43 to interact with PAR in mammalian cells, and are in support of our data that the PBMs mediate binding to PAR (Figure 2) .
To determine whether mutation in the PBM also reduced TDP-43 localization to stress granules, we rigorously characterized TDP-43-GFP before and after stress. As anticipated, TDP-43-WT-GFP was predominantly nuclear (Figure 5B) , whereas mutation in the PBMs (TDP-43-DPBM-GFP), which is known to prevent nuclear localization (Winton et al., 2008) , resulted in diffuse cytoplasmic accumulation ( Figure 5B ). Upon stress, the percentage of cells with cytoplasmic foci of TDP-43-WT and TDP-43-DPBM increased to 23.7% ± 3% and 89.7% ± 4.9% (SEM), respectively (Figures 5A-5C and S3I and S3J); furthermore, the stress-induced foci of TDP-43-WT, but not TDP-43-DPBM, co-labeled with the stress granule markers G3BP1 and TIAR ( Figures 5B, 5D -5F, and S3I-S3K). Staining with additional markers of stress granules (Ataxin-2 and eIF3) in mammalian cells, immunostaining with TIAR in rat primary neurons, and exposure to a different stress (heat shock) confirmed that TDP-43-WT was recruited to PARcontaining stress granules, whereas stress-induced foci of TDP-43-DPBM were excluded from these stress granules ( Figures  S4A-S4F ). Together, these data suggest that a functional PBM is required for TDP-43 to localize to stress granules.
To determine whether PAR binding was necessary for TDP-43 recruitment to stress granules, we added an exogenous PBM from hnRNPA2/B1 (Gagné et al., 2003) to TDP-43-DPBM (Figure 5A ). The PBM in hnRNPA2/B1 is distinct from the NLS and is situated in the N-terminal domain between the two RNA recognition motifs (RRMs) (Gagné et al., 2003) . Under normal conditions, TDP-43-DPBM PBM-A2/B1 was diffusely enriched in the cytoplasm ( Figure 5B), indicating that the PBM of hnRNPA2/B1 did not alter the cellular distribution of TDP-43-DPBM. The application of stress initiated the formation of cytoplasmic TDP-43-DPBM-PBM-A2/B1 foci ( Figures 5B and 5C ). Strikingly, the exogenous PBM significantly increased the percentage of cells with TDP-43-DPBM localized to G3BP1-labeled stress granules from 0.6% ± 0.4% (SEM) to 23.7% ± 9% (Figures 5D-5F ). Thus, the addition of a functional PAR-binding motif is sufficient to restore stress-granule accumulation of TDP-43 defective in PAR binding (TDP-43-DPBM). We suggest that the localization of TDP-43 to stress granules is dependent on PAR-binding.
We next addressed whether the C-terminal fragments of TDP-43, which lack the N terminus and PBMs, could localize to stress granules. TDP-43-C35-GFP and TDP-43-C25-GFP, which normally diffusely localized to the nucleus and cytoplasm, formed cytoplasmic foci upon arsenite treatment ( Figures  5F-5I ). TDP-43-C35 retains PBM2 and localized to 43.5% ± 3.4% (SEM) of TIAR-labeled stress granules ( Figures 5F-5H ). By contrast, TDP-43-C25 localized to 2.3% ± 1.3% (SEM) of TIAR-labeled stress granules ( Figures 5F-5H ). These data indicate that the N-terminal region of TDP-43 is important for the recruitment of the protein to stress granules and suggest that, in disease, stress-granule recruitment of the C-terminal fragments of TDP-43 will be partially (C35) or almost fully (C25) impaired.
Recruitment to Stress Granules Inhibits Phosphorylation of TDP-43
A long-standing notion is that TDP-43 recruited to stress granules becomes marked with the phosphorylation hallmark of disease (Li et al., 2013) . To test this, we examined phosphorylation of TDP-43 foci that were localized to, or excluded from, stress granules. Surprisingly, staining for the disease-specific phosphorylation mark pS409/10 revealed that arsenite-induced and heat-induced foci that were excluded from stress granules (TDP-43-DPBM, C35, and C25), but not TDP-43 localized to stress granules (TDP-43-WT), were phosphorylated (Figures 6A-6C and S5A-S5E). We then examined the phosphorylation status of TDP-43-DPBM with an exogenous PBM (TDP-43-DPBM PBM-A2/B1 ). Importantly, the percentage of cells with arsenite-induced cytoplasmic foci of TDP-43-DPBM PBM-A2/B1 that co-labeled with pS409/10 was indistinguishable from TDP-43-WT ( Figures S6D-S6F ), indicating that the exogenous PBM was sufficient to both localize TDP-43-DPBM to stress granules (Figure 5 ) and prevent stress-induced phosphorylation.
Next we established a live-cell assay to examine the internal dynamics of stress-induced foci of TDP-43. Diffuse TDP-43-WT and TDP-43-DPBM in the cytoplasm recovered rapidly from photobleaching (Figures S5F and S5G) , indicating that the two proteins were normally highly mobile. By contrast, stressinduced, cytoplasmic foci formed by both proteins were immobile (Figures S5F and S5G) . However, the stress-induced foci of TDP-43-WT resolved after the removal of stress, whereas the forms of the protein that aggregated outside of the stress granule persisted ( Figure S5H ). These data indicate that localization of TDP-43 to the stress granule environment is critical for preventing stress-induced phosphorylation and for the resolution of TDP-43 foci upon recovery from stress.
We next determined whether there were conditions of stress that could promote phosphorylation of TDP-43-WT. Intriguingly, low levels of prolonged stress (25 mM arsenite for 6 hr) led to an increase in the percentage of cells with cytoplasmic TDP-43-WT foci, the majority (81% ± 6% [SEM]) of which were phosphorylated and devoid of the stress granule protein eIF3 ( Figures  S6A-S6E ). In addition, exposure to high levels of stress for a prolonged period (0.5 mM arsenite for 4 hr) led to the formation of, and the subsequent resolution of, G3BP1-labeleld stress granules ( Figure 7A ). By contrast, stress-induced foci of TDP-43-WT were sustained over this time period (Figure 7B) , and in 78% ± 8% (SEM) of cells, the TDP-43-WT foci were immunolabeled for pS409/10 and devoid of G3BP1 ( Figures 7C and 7D ). Thus, consistent with our finding that the stress granule environment inhibits S409/410 phosphorylation, prolonged stress induces the formation of phosphorylated TDP-43-WT foci in the absence of stress granules.
Small-Molecule Inhibition of Tankyrase Inhibits StressInduced Foci of TDP-43
Our studies were launched by the discovery that lowered levels of tankyrase mitigate TDP-43-elicited neurodegeneration in the fly. We thus examined the role of Tankyrase to modulate stress-induced foci of TDP-43 in mammalian cells. In mammals, there are two Tankyrase homologs, Tankyrase 1 and Tankyrase 2 (also known as PARP-5a and PARP-5b), which share 82% sequence similarity and are collectively detected as Tankyrase 1/2 (Citarelli et al., 2010) . Under stress, Tankyrase-1/2 localized to 35% ± 9% (SEM) of Ataxin-2-labeled stress granules and to 31% ± 2% (SEM) of TIAR-labeled stress granules ( Figure S7A ). Thus, Tankyrase 1/2 is not a constitutive stress granule protein.
Tankyrase-1/2 inhibitors have been developed as anti-proliferative agents for cancer cells (Mariotti et al., 2017) . We examined small-molecule inhibition of Tankyrase-1/2 for an effect on stress granule biogenesis and TDP-43 focus assembly. Treatment with (B) Normally, TDP-43-WT was nuclear, and TDP-43-DPBM and TDP-43-DPBM PBM-A2/B1 were cytoplasmic. Upon arsenite treatment, TDP-43-WT and TDP-PBM PBM-A2/B1 localized to stress granules whereas TDP-43-DPBM was excluded from stress granules. Cells were exposed to 0.5 mM sodium arsenite for 1 hr, labeled for G3BP1, and stained with Hoechst. (C) The percentage of cells with cytoplasmic TDP-43-GFP foci. Mean (± SEM), n = 3, two-way ANOVA (p < 0.0001), and Holm-Sidak's test. Asterisks, significant. (D) The percentage of cells with one or more G3BP1-labeled stress granule (SG) co-labeled with TDP-43-GFP. Mean (± SEM), n = 3, one-way ANOVA (p < 0.0001), and Tukey's test. Asterisks, significant. (E) The percentage of G3BP1-labeled SGs co-labeled with TDP-43-GFP. Mean (± SEM), n = 3, one-way ANOVA (p < 0.0001), and Tukey's test. Asterisks, significant. (F) The percentage of TDP-43-GFP foci co-labeled with G3BP1. Mean (± SEM), n = 3, one-way ANOVA (p < 0.0001), and Tukey's test. Asterisks, significant. (G) Under normal conditions TDP-43-WT-GFP was diffusely nuclear, whereas TDP-43-C35-GFP and TDP-43-C25-GFP were diffusely nuclear and cytoplasmic. Cells were labelled for TIAR and stained with Hoescht (DNA). (H) Foci of TDP-43-C35 and TDP-43-C25-GFP are largely excluded from stress granules. Cells were exposed to 0.5 mM sodium arsenite for 1 hr, labeled for TIAR, and stained with Hoechst (DNA). (legend continued on next page) the inhibitor XAV939 (Huang et al., 2009 ) markedly reduced the formation of arsenite-induced cytoplasmic foci of TDP-43-WT-GFP without altering the percentage of cells with G3BP1-labeled stress granules (Figures 7E-7G) . Two additional inhibitors, G007-LK and IWR-1-endo, with little to no effect on PARP-1/2 activity (Huang et al., 2009; Voronkov et al., 2013) behaved similarly . Thus, Tankyrase-1/2 activity regulates the formation of cytoplasmic TDP-43 foci but not stress granule formation. Together, our data suggest that reduced Tankyrase-1/2 activity mitigates ALS-associated degeneration by reducing the cytoplasmic localization of TDP-43 and subsequent neurodegeneration.
DISCUSSION
Our data has led to a two-step model for regulation of TDP-43 whereby Tankyrase-1/2 regulates the formation of cytoplasmic foci of TDP-43 and PAR regulates the recruitment of TDP-43 to stress granules. Under prolonged stress, stress-induced foci of TDP-43 become marked with the disease signature of phosphorylation. Importantly, small-molecule inhibitors of Tankyrase reduce the formation of TDP-43 foci in the cytoplasm. Thus, Tankyrase regulates the subcellular localization of TDP-43 and mitigates TDP-43-mediated neurodegeneration. Small-molecule inhibitors of Tankyrase-1/2 may provide a therapeutic strategy for ALS/FTD.
The N-Terminal Domain and PBMs Regulate TDP-43 LLPS and Stress Granule Recruitment
We have defined functional PBMs embedded in the TDP-43 NLS that are required for TDP-43 LLPS. Mounting evidence implicates the N-terminal domain of TDP-43 as critical for higher-order assemblies (Afroz et al., 2017; Chang et al., 2012; Jiang et al., 2017; Mompeá n et al., 2016; Romano et al., 2015; Zhang et al., 2013) . Our data, and a report that that pinpoints serine 48 in the N-terminal domain (Wang et al., 2018) , indicate that the N-terminal domain is also critical for TDP-43 phase separation in vitro. We show that the negatively charged PAR biopolymer can initiate LLPS of TDP-43 and suggest that this occurs via multivalent interactions with the PBM in the N-terminal domain.
In the cellular milieu, TDP-43 is not a ubiquitous stress granule protein and does not readily localize to the cytoplasm (Bentmann et al., 2012; Cohen et al., 2012; Dewey et al., 2011) . Previous studies have focused on TDP-43 with mutation in the NLS without a comparison with the WT protein (Bentmann et al., 2012; Nonaka et al., 2009) . Here, by successfully inducing the accumulation of TDP-43-WT in the cytoplasm, we were able to uncover the essential role of the PAR binding and N-terminal regions for the recruitment of TDP-43 to stress granules. Importantly, the addition of the PAR-binding motif from hnRNPA2/B1 to TDP-43-DPBM was sufficient to re-localize TDP-43-DPBM back to stress granules. The PBM from hnRNPA1/B2 did not alter the cytoplasmic localization of TDP-43-DPBM, suggesting that the lack of stress granule recruitment was not a result of a loss of nuclear localization but due to loss of PAR binding. Direct PARylation of specific stress granule proteins assists with stress granule formation (Leung et al., 2011) , and we propose that noncovalent PAR-binding is an added means by which proteins enter stress granules. Interestingly, the C35 fragment retains PBM2 and is only partially localized to stress granules upon stress. The partial exclusion of C35 and the almost complete exclusion of C25 from stress granules could be due to a lack of binding to the PAR scaffold or because these forms of TDP-43 undergo aberrant phase separation.
Recruitment to Stress Granules Inhibits Phosphorylation of TDP-43
Our studies refine the long-standing model that stress granule localization of TDP-43 nucleates disease-associated pathology (Li et al., 2013) . We present a model whereby TDP-43 foci excluded from stress granules readily transition into diseaselike aggregates. Various kinases promote stress granule biogenesis (Kedersha et al., 2013) , and it is possible that TDP-43 aggregates excluded from stress granules are exposed to and phosphorylated by these stress-responsive kinases. We suggest that an additional role of stress granules is to protect proteins from the activated kinases during cellular stress. In disease, the phosphorylation and aggregation of C35 and C25 may arise from a failure to phase-separate and localize to stress granules. TDP-43 that can localize to stress granules becomes phosphorylated upon long-term stress and in the absence of stress granules. This finding may explain why only a subset of TDP-43 inclusions in the post-mortem spinal cord co-labels with stress granule components (Bentmann et al., 2012; Colombrita et al., 2009; McGurk et al., 2014) . Stress granule protein may become trapped in TDP-43 aggregates as the stress granules dissolves. Thus, in the spinal cord, TDP-43 may be recruited to stress granules and be protected but may transition to a pathological aggregated state as a result of the stress granule dissolution process.
Tankyrase-1/2 as a Potential Therapeutic Strategy in ALS and FTD It has been reported that upregulation of Tankyrase-1 promotes stress granule formation (Leung et al., 2011) . Our studies uncover that Tankyrase-1/2 is not a ubiquitous stress granule protein and that Tankyrase-1/2 inhibition does not alter the formation of G3BP1-labeled stress granules. It is possible that Tankyrase-mediated regulation of stress granules may be independent of enzymatic activity or may only occur in select stress granules or on select proteins such as TDP-43. We hypothesize that Tankyrase-1/2 acts upstream of TDP-43 recruitment to stress granules and may regulate the transport of TDP-43 to stress granules. Although stress granule localization is initially protective, prolonged stress leads to phosphorylated (E) The percentage of cells with cytoplasmic TDP-43-GFP (WT, DPBM, or DPBM PBM-A2/B1 ) foci co-labeled with pS409/10. Mean (± SEM), n = 3, one-way ANOVA, and Dunnett's test (normal, p < 0.0001; arsenite, p = 0.0024). (Figures S7H and S7I) . Arrows, cells with cytoplasmic TDP-43-WT-GFP foci. Cells were labeled for G3BP1 and Hoechst.
(legend continued on next page) aggregates. A potential therapeutic strategy could be to target Tankyrase-1/2 activity to inhibit the initial accumulation of TDP-43 in the cytoplasm. Our studies bring PARylation in ALS/FTD to the forefront and specifically implicate Tankyrase inhibitors as potential therapeutics in ALS/FTD.
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Drosophila: UAS-TDP-43 (37M)/CyO; gmr-GAL4(YH3)/TM6B
CONTACT FOR REAGENT AND RESOURCE SHARING
Requests for resources, reagents and further information should be directed to, and will be fulfilled by, Nancy M. Bonini (nbonini@sas. upenn.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Drosophila stocks and maintenance All Drosophila stocks are described in the Key Resources Mammalian cells and culture details COS-7 cells were originally purchased by ATCC and were kindly provided by Virginia M. Lee, University of Pennsylvania. Cells were authenticated by ATCC before purchase. The cell lines were not tested for mycoplasma contamination. No commonly misidentified cell lines were used. Cells were routinely cultured in Dulbecco's modified Eagle's medium (DMEM) with high glucose supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Cells were grown at 37 C with 5% CO 2 , and a water bath was used for humidification. Cells were washed with Dulbeccos PBS without calcium and without magnesium and trypsinized in Trypsin with 0.25% EDTA (ThermoFisher Scientific).
Rat cortical neuron cultures
Studies were approved by the Children's Hospital of Pennsylvania Institutional Animal Care and Use Committee (CHOP IACUC), the assigned protocol number was 594. All studies adhered to all regulatory standards. Rat cortical neuron cultures were prepared from embryos isolated from female Sprague Dawley wild rats that were 16-18 days pregnant. Neurons were cultured as previously described (Mojsilovic-Petrovic et al., 2006) . Briefly, tissue was dissociated with 5% trypsin and 1mg/ml DNase, cells were cultured in 12-well plates in conditioned neuralbasal medium with serum-free B-27 (ThermoFisher Scientific) and penicillin-streptomycin (ThermoFisher Scientific). After 3-4 days in vitro (DIV) cell division was stopped by the addition of 5 mM cytosine arabinoside (AraC) (Sigma-Aldrich). Cells were maintained in preconditioned neuralbasal medium with serum-free B-27 (ThermoFisher Scientific) and penicillin-streptomycin (ThermoFisher Scientific).
METHOD DETAILS
Drosophila external eye imaging and histology External eyes and internal retinas were imaged in female flies aged 2-3d. For quantification, the integrity of the external eye was scored in ten female flies from three independent crosses for each genotype. Control and experimental crosses were propagated at the same time and incubated in the same incubator (25 C). The internal retina was quantified using imageJ (Rueden et al., 2017) from paraffin sections at the same anatomical position for all animals. Three sections per animal were imaged and quantified, this was repeated on 3-5 female heads from each genotype.
Drosophila lifespan
For lifespan analysis, more than 190 males (1d-old) for each genotype were separated into groups of 15-20 and aged in vials containing fresh standard cornmeal molasses agar. Every second day dead flies were scored and the survivors were tipped into a fresh food vial. Kaplan-Meir survival curves were plotted and a log-rank test for trend was performed using Graphpad prism 6. The lifespan analysis was repeated three independent times at different times throughout the year.
Nuclear Cytoplasmic fractionation
The NER-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific) was used to fractionate the nuclear and cytoplasmic protein from fly heads. The instructions were followed with the following modifications: 10 male heads were homogenized in 110 mL of ice-cold CERI for 1 minute, the sample was vortexed on the highest setting for 30 s to fully suspend the cell pellet. The sample was incubated the on ice for 10 min and then 5.5 mL of ice-cold CER II was added. The sample was vortexed for 10 s on the highest setting, and then incubated on ice for 2 mins. The sample was vortexed on the highest setting for 15 s and then centrifuged at maximum speed for 10 mins at 4 C. The supernatant (cytoplasmic extract) was immediately transferred to a clean pre-chilled tube. The supernatant was spun again at maximum speed for 10 min at 4 C, the supernatant (cytoplasmic extract) was transferred to a pre-chilled tube. The nuclear pellet was washed in 50 mL of ice-cold CERI, and then centrifuged at maximum speed for 10 min at 4 C. The supernatant was discarded and the pellet was resuspended in 55 mL of ice-cold NER. The samples were vortexed on the highest setting for 10 s every 10 min for a total of 40 mins. The samples were centrifuged at maximum speed for 10 mins at 4 C. The supernatant (nuclear fraction was transferred to pre-chilled tube. Samples for immunoblotting were made up in 1X LDS loading buffer, with 5% b-mercaptoethanol, heat denatured at 95 C, chilled for 5 min and centrifuged at 5000 rpm for 5 mins at 4 C. For the total protein immunoblots that correspond to the nuclear and cytoplasmic fractionation, 10 male heads were homogenized in 100 mL Laemelli buffer with b-mercaptoethanol, heat denatured at 95 C, chilled for 5 min and centrifuged at 5000 rpm for 5 mins at 4 C. The equivalent of half of a fly head was loaded into each well for each sample type (nuclear, cytoplasmic and total). Protein was electrophoresed on 4%-12% Bis-Trsi gel and transferred onto nitrocellulose by wet transfer (20 volts for 75 mins). Blots were blocked in 5% milk in TBS supplemented with 0.05% TWEENÒ20 pH 8 (TBST). Primaries made up in TBST were rabbit anti-TDP-43 (1 in 3000, Proteintech), then mouse anti-Lamin A/C (1 in 1000, DSHB) and then anti-tubulin-HRP (1 in 1,000; Cell Signaling Technology). TDP-43 was always detected first, tubulin, migrates closely to TDP-43, and will interfere with TDP-43 signal detection. Secondary antibodies made up in TBST were anti-mouse HRP (1 in 5000, abcam) and anti-Rabbit-HRP (1 in 5000, EMD Millipore). TDP-43 was detected with ECL (GE healthcare Bio-Sciences) and Tubulin and Lamin A/C were detected with ECL Prime (GE Healthcare Bio-Sciences). Quantification of protein blots was performed using ImageJ software (Rueden et al., 2017) . All experiments were carried out on three or more biological replicates and statistical analysis was carried out using prism 6 software.
Immunoblotting of Drosophila total protein
For experiments where the transgene (TDP-43 or LacZ) was expressed in the eye with gmr-GAL4, protein was extracted from 10 female heads in 100 mL of 2X Laemelli buffer with 5% (v/v) b-mercaptoethanol, heat denatured at 95 C, chilled on ice for 5 mins and centrifuged at 5000 rpm for 5 mins at 4 C. The equivalent of half of a fly head was loaded into each well of a 4%-12% BisTris gel and transferred onto nitrocellulose by wet transfer (20 V for 75 mins). Blots were blocked in 5% milk in TBST (TBS supplemented with 0.05% TWEENÒ20 pH 8.0). Primary antibodies made up in TBST were: TDP-43 (1 in 3000; Proteintech), a-Tubulin-HRP (1 in 1,000; Cell Signaling Technology) and bÀgalactosidase (1 in 1,000; Promega). HRP-coupled secondary antibodies used: goat antibody to rabbit (1 in 5,000; EMD Millipore) and goat antibody to mouse (1 in 2,000; Jackson ImmunoResearch Laboratories, Inc.). All experiments were carried out on three or more biological replicates, blots were quantified with ImageJ (Rueden et al., 2017) and statistical analysis was carried out using Graphpad prism 6 software.
Real-time PCR 20 third instar larvae from each genotype were homogenized in 250 ml of Trizol. A further 250 mL of Trizol and 100 ml of chloroform was added and the tube was vigorously shaken for 15 s at room temperature. The samples were centrifuged at maximum speed for 10 min at 4 C and the upper-aqueous phase was transferred to a fresh and pre-chilled tube. The chloroform extraction was repeated on the aqueous phase. RNA was precipitated in 2 volumes of 100% ethanol and 1/10 th the volume of 3 M sodium acetate pH 5.2, and the RNA sample was left on ice for 25 mins. The samples were then centrifuged at maximum speed at 4 C for 10 mins. The RNA pellet was washed in 70% ethanol and centrifuged at maximum speed at 4 C for 10 mins. The pellet was air-dried and the RNA was dissolved in 40 mL of DEPC-treated water. Genomic DNA in half of the RNA sample was digested with turbo DNase (Ambion) using the vigorous protocol. 500 ng of RNA was used for first-strand DNA synthesis by Superscript III (ThermoFisher Scientific) with random primers. Fast SYBR Green (ThermoFisher Scientific) was used for real-time analysis. Standard curves were used to test the efficiency of all the primers and to determine the amount of cDNA to add to the PCR reaction. Each experiment was carried out on larvae prepared from 4 independent fly crosses. Statistics were calculated using Graphpad prism 6 software. Primers used were: 
Co-immunoprecipitation
To co-immunoprecipitate PARylated protein and TDP-43 from male fly heads the Pierce co-immunoprecipitation kit (ThermoFisher Scientific) was used according to the manufacturer's instructions. Briefly, 100 mL (1mg/ml) of anti-PAR (clone 10H, BSA free, Tulip Biolabs) was diluted in 100 mL of PBS and desalted using 2ml Zeba desalting columns (Thermo scientific). 33 mg of desalted antibody was immobilized to the agarose resin. Adult male flies, expressing TDP-43 with elav-GAL4, were aged to day 4, a total of no more than 22 heads were homogenized for 1 min on ice in 200 mL of IP Lysis/wash buffer (Thermo Scientific), that was supplemented with cOmplete Mini EDTA-free inhibitor (Roche) and ADP-HPD (Calbiochem) at a final concentration of 1 mM. A total of 20 mL was removed for input. Samples were pre-cleared with agarose (1 hr with gentle shaking at 4 C). Precleared lysate was incubated with the antibody-agarose resin at 4 C for 14 hrs, then washed 3 times in lysis buffer containing protease inhibitor and 1 mM ADP-HPD (10 mins each with rotation at 4 C), and eluted in 50 mL of elution buffer. Samples for immunoblotting were prepared in 1X LDS sample buffer, heat denatured at 90 C for 6 min and electrophoresed on a NuPAGE 4%-12% Bis-Tris gel. TDP-43 was detected using anti-TDP-43 (1 in 250; Proteintech) and ECL Prime (GE Healthcare Bio-Sciences).
COS-7 cells were lysed in IP Lysis buffer (Thermo Scientific) containing 1 mM ADP-HPD (Calbiochem) and cOmplete Mini EDTAfree inhibitor (Roche). Lysate was removed for input analysis and the remaining cell lysate was pre-cleared in either Agarose-G or dynabeads TM protein G (both ThermoFisher Scientific) for 1 hr at 4 C. 5 mg of anti-TDP-43 (Proteintech), 5 mg of anti-PAR (10H) BSA free (Tulip Biolabs) and 5 mg of anti-PAR (Enzo life sciences) were coupled to 50 ml of Agarose-G or dynabeads TM protein G and incubated with the precleared lysate. The beads were washed once in lysis buffer, once in lysis buffer supplemented with 300 mM NaCl, and once more in lysis buffer (each 10 min with rotation at 4 C). Beads were denatured at 70 C for 10 min in 1X LDS buffer and electrophoresed on a NuPAGE 4%-12% Bis-Tris gel. Antibodies used for detection were rabbit anti-TDP-43 (1 in 3000; Proteintech), rabbit anti-PAR LP-96 (1 in 500; BD Biosciences). HRP-coupled secondary antibodies used: goat antibody to rabbit (1 in 5,000; EMD Millipore) and goat antibody to mouse (1 in 2,000; Jackson ImmunoResearch Laboratories, Inc.).
Plasmids
Human TDP-43 in pDuet-GST was previously described (Johnson et al., 2009) . Human TDP-43-WT-YFP cloned in to pcDNA3.2 was described previously (Elden et al., 2010) . Full-length human TDP-43, TDP-43-C35 (amino acids 85-414) and TDP-43-C25 (amino acids 176-414) were subcloned into pE-SUMO (LifeSensors).
TDP-43-WT, TDP-43-DPBM, TDP-43-C35 (amino acids 85-414) and TDP-43-C25 (amino acids 176-414) were subcloned into pcDNA3-C-eGFP by GenScript. TDP-43-MBP-His 6 in PJ4M/TDP-43, obtained from ADDGENE, was described previously (Wang et al., 2018) . PBM1 and PBM2 mutations were generated in TDP-43-WT-YFP (pcDNA3.2), GST-TDP-43-WT (pDuet-GST) and SUMO-TDP-43-WT (pE-SUMO) by performing site directed mutagenesis (QuikChange II XL) using the following primers:
The Q331K mutation in TDP-43-WT (pE-SUMO) was generated by site directed mutagenesis (QuikChange II XL) using the following primer:
The DNA sequence corresponding to the hnRNPA1/B2 peptide, was cloned immediately upstream of the stop site in TDP-43-DPBM in pcDNA3-C-eGFP, by GenScript, to create TDP-43DPBM-PBM-A2/B1 . The DNA sequence subcloned was:
All plasmid inserts were sequenced and confirmed to be free of any errors.
Cell stress assays and immunofluorescence COS-7 cells were seeded at an appropriate density onto glass coverslips coated with poly-L-lysine (neuVitro) in 24 well plates. The following day each well was transfected with 500 ng of plasmid DNA, 1.75 mL lipofectamine LTX and 0.5 mL PLUS reagent in 100 mL of OPTIMEM I (all ThermoFisher Scientific). For phosphorylation of the TDP-43-WT, TDP-43-C35 and TDP-43-C25 cells were transfected with lipofectamine 2000 (ThermoFisher Scientific), all other transfections of Cos-7 cells used lipofectamine LTX. Again 500 ng of plasmid with 1.75 mL of lipofectamine 2000 were made up in 100 mL of OPTIMEM I and incubated at room temperature for 5 mins. All transfection mixtures were added to each well containing 400 mL of DMEM with high glucose supplemented with 10% FBS and no antibiotics. Transfection mixtures were left on overnight until the time of the experiment. All experiments begun 19-24 hr post-transfection. Cells were exposed to oxidative stress by incubating cells at 37 C with 5% CO 2 in either DMEM supplemented with 10% FBS and antibiotics or DMEM media supplemented with 10% FBS, penicillin-streptomycin and the indicated concentration of sodium arsenite (Sigma-Aldrich). For stress-resolution experiments, cells were exposed to 0.25 mM sodium arsenite for 1 hr and then washed with PBS twice and then incubated in pre-warmed DMEM with 10% FBS and antibiotics. See below for immunofluorescence details.
For drug inhibitor assays, Cos-7 cells were grown on glass coverslips in 24-well plates and transfected with lipofectamine LTX as described above. Transfection mixtures were not removed. Cells were incubated with 1 mM XAV-939 (SelleckChem), G007-LK (SelleckChem) in DMEM with high glucose and 10% FBS for 30 mins at 37 C with 5% CO 2 before the application stress. For IWR1-endo (SelleckChem) experiments, cells were incubated in either 0.5 mM, 1 mM or 10 mM of drug for 30 mins at 37 C with 5% CO 2 prior to stress. For all drugs, cells were exposed to 0.25 mM sodium arsenite in DMEM with high glucose and 10% FBS and the indicated amount of drug for 30 mins at 37 C with 5% CO 2 . Experiments commenced 22-23 hr after transfection. See below for immunofluorescence see details.
Primary cortical neurons, in 12-well plates, were cultured in neuralbasal medium with serum-free B-27 (ThermoFisher Scientific) and penicillin-streptomycin (ThermoFisher Scientific). Transfection was carried 6 DIV. Immediately before transfection the culture media was removed and cells were washed twice in pre-warmed PBS with calcium chloride and magnesium chloride (ThermoFisher). 1 ml of pre-warmed neuralbasal medium supplemented with B27 was added to each well. Transfection reactions were made up in a total of 200 mL of OPTIMEM I (ThermoFisher Scientific) and contained 500 ng or 1000 ng (both work well) of plasmid DNA and 2 mL of lipofectamine 2000 (ThermoFisher Scientific). Transfection mixtures were left at room temperature for 5 minutes before being added to the well. The transfection media was removed after 6 hr, each well was washed twice with pre-warmed PBS with calcium chloride and magnesium chloride, and then the cells were returned to pre-warmed and conditioned neuralbasal media supplemented with serum-free B-27 (ThermoFisher Scientific) and penicillin-streptomycin (ThermoFisher Scientific). The neurons were stressed 10 DIV (4 days post-transfection). Transected neurons were stressed in 0.5 mM sodium arsenite for 90 min. See below for immunofluorescence see details.
Neurons and COS-7 cells were fixed for 15 min in 4% paraformaldehyde (made up in 50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM MgCl and 1 mM EGTA), permeablized by 3 sets of 3 mins in PEM-T buffer (100 mM PIPES, 1 mM MgCl2, 10 mM EGTA pH 6.8, and 0.1% Triton X-100), and blocked in 10% normal donkey serum (Sigma-Aldrich) made up in TBST (TBS supplemented with 0.05% TWEEN 20 pH 8). Primary antibodies were applied overnight at 4 C (see below for antibody details) in a humidified chamber, cells were washed 3 times in PEM-T buffer (3 mins each) and secondary antibody was applied for 45 mins (COS-7 cells) or 1 hr (neurons) at room temperature and in the dark. Cells were washed 3 times in TBST (3 mins each), cells were stained with Hoescht for 5 mins and coverslips were washed in deionized H 2 0 immediately before mounting in prolong diamond.
For detection of PAR, endogenous TDP-43 and Tankyrase in arsenite-induced stress granules, cells were washed twice in dPBS without magnesium and without calcium and extracted in 50 mM HEPES pH 6.8, 150 mM NaCl, 1 mM MgCl 2 , 1 mM EGTA and 0.1% Triton X-100 for 30 s before fixing. Cells were fixed for 15 mins in 4% paraformaldehyde, permeabilized in PEM-T (3 incubations, 3 mins each), then in 100 mM sodium periodate (Sigma-Aldrich) made up in PEM-T for 5 mins, washed in PEM-T for 3 mins, 25 mM succinic dihydrazide (Sigma-Aldrich) made up in PEM-T (30 mins), 3 washes in PEM-T (3 mins each) and then blocked in 10% normal donkey serum in TBST (TBS supplemented with 0.05 % TWEEN 20 pH 8) for 1 hr at room temperature.
Primary antibodies used for both COS-7 and neurons: mouse anti-TIAR (1 in 500; BD Biosciences), mouse anti-Ataxin-2 (1 in 500; BD Biosciences), rabbit anti-G3BP1 (1 in 1000; Thermo Scientific), goat anti-eIF3 (1 in 50; Santa Cruz Biotechnology), mouse anti-eIF3 (1 in 500; Santa Cruz Biotechnology), rabbit anti-TDP-43 (1 in 300, Proteintech), mouse anti-PAR (1 in 400: Tulip BioLabs), mouse anti PAR (1 in 400, ENZO), mouse pS409/10 (1 in 1000; Cosmo Bio USA) and rabbit pS409/10 (1 in 1000; Cosmo Bio USA). Alexa Fluor À488, À568, À594 and À647 secondary antibodies were used for detection (all 1 in 500; Thermo Scientific).
All experiments were performed at least three independent times.
Image quantification and statistics
All imaging was performed on a Leica DMI6000 unless stated otherwise. To quantify the formation of stress granules in the cytoplasm we captured 4-8 independent images at 20X. The number of cells were quantified by ImageJ software (Rueden et al., 2017) and up to 900 cells per condition per experiment were quantified. The number of cells with 2 or more stress granules were counted. An overall percentage was obtained from three independent experiments and the mean (± SEM) was calculated. To quantify TDP-43-foci formation 4 non-overlapping images at 20X were captured for the WT, C35 and C25 experiments and up to 66 transfected cells were quantified per condition per experiment. These experiments were repeated 3 independent times and a mean (± SEM) was calculated. For the PBM hnRNPA2/B1 experiments 6 independent images at 20X were captured and up to 391 transfected cells were quantified. These experiments were repeated 3 independent times and a mean (± SEM) was calculated.
To quantify the recruitment of TDP-43 to stress granules we captured 4-5 independent images at 40X of cells that had both TIAR-labeled stress granules (or one of the other stress granule markers) and cytosolic TDP-43 foci, up to 440 stress granules were quantified per condition per experiment. A mean (± SEM) was calculated from three independent experiments. To quantify the percentage of TDP-43-GFP foci co-labeled with G3BP1 or TIAR, the same images were analyzed and up to 1419 TDP-43-GFP foci were quantified for the presence of TIAR or G3BP1. These experiments were repeated 3 independent times and a mean (± SEM) was calculated.
To quantify the recruitment of TDP-43 to neuronal stress granules we imaged up to 6 transfected neurons and up to 40 stress granules per condition and quantified the number of stress granules localizing with TDP-43. A mean (± SEM) was calculated from three independent experiments.
To quantify the phosphorylation of TDP-43-WT, C35 and C25, 4 non-overlapping images were captured at 20X magnification for each condition, up to 124 transfected cells were quantified per condition per experimental repeat. The percentage of cells with TDP-43 foci and phosphorylated foci was calculated for each condition. For the PBM hnRNPA2/B1 , experiments 6 non-overlapping images were captured at 20X magnification for each condition, up to 700 transfected cells were quantified. These experiments were repeated 3 independent times and a mean (±s.e.m.) was calculated.
All triple labeled experiments were imaged using a Leica SP5 confocal. TFP-43-YFP and TDP-43-GFP alone were used as a control slide to optimize the settings for fluorescence bleed through. Cells with both G3BP1/TIAR/eIF3-labeled stress granules and cytoplasmic TDP-43-YFP or TDP-43-GFP foci were imaged at 40X magnification, 7-27 transfected cells were quantified per condition per experiment. Experiments were performed 3-5 independent times. Statistics for all experiments were performed using Graphpad prism 6 software.
Statistics (t tests, one-way ANOVA, two-way ANOVA and multiple comparison tests) for all experiments were performed using Graphpad prism 6 software, the details for each experiment are described in each legend.
Fluorescence recovery after photobleaching COS-7 cells were cultured as described above. For live cell-culture experiments COS-7 cells were grown in a poly-d-lysine coated glass bottom 35 mm culture dish (MatTek). Cells were transfected with using 7 mL lipofectamine LTX, 2 mL of plus reagent (both ThermoFisher Scientific) and 2000 ng of plasmid DNA in a total of 400 mL of OPTIMEM I (all ThermoFisher Scientific) in 1.6 mL DMEM with high glucose and 10% FBS. The transfection reagent was not removed and experiments were performed 21 hr after transfection. FRAP experiments were performed on a laser scanning Leica SP8 confocal with the FRAP module located at the CDB microscopy core, University of Pennsylvania. A cell-culture climate chamber was attached to the microscope stage. The temperature control of the chamber was previously calibrated with thermocouple measurements such that heating the outside of the chamber to 39 C gave an internal temperature of 37 C. An objective heating collar was attached to a 40X water immersion objective and the temperature was set to 33 C. The chamber was attached to a mixed gas chamber. The cell-culture dish was placed in the chamber, the media was removed and rinsed in PBS and then incubated in DMEM with high glucose, 10% FBS and 1x penicillinstreptomycin in the presence or absence of 0.25 mM sodium arsenite.
For FRAP experiments, images collected were 12 bit and at a resolution of 512 by 64. Scanning was unidirectional and at frequency of 1800 Hz with a zoom of 7.5 and a line average of 1. Care was taken to assure that the temperature of the microcopy room did not increase above 23 C during data acquisition. Conditions for diffuse TDP-43 were; pre-bleaching, 0.2% of the 488 nm laser, for 90 iterations at 76 ms; for bleaching, 100% of the 488 nm laser was used for 360 iterations at 76 ms; and for post-bleach, 0.2% of the 488 nm laser for 2500 iterations at 76 ms was used. Conditions for the TDP-43 foci for pre-bleaching, 0.2% of the 488 nm laser, for 50 iterations at 76ms; for bleaching, 100% of the 488 nm laser for 150 iterations at 76 ms to bleach and 0.2% of the 488 nm laser for 1750 iterations at 76 ms for the post-bleach. One GFP-positive granule was bleached per cell. Bleaching was focused on a circular region of interest (ROI) set to 1 micron in diameter. For early stress, cells were bleached from 30 mins to 1 hr and for late stress cells were bleached after 2 hr of treatment. 7 to 14 cells were bleached for each condition. Each experiment was more than performed 3 independent times and on different days. After image capture, an ROI was applied to a non-bleached GFP-positive granule (to account for photobleaching). The intensity data of the ROIs were normalized and exported as a csv file.
To determine the rate of fluorescence recovery (FR) the fluorescence of the bleached ROI was normalized to the unbleached ROI at every time point (t) to take into account changes in fluorescence during image acquisition: Each condition was repeated three times each on different days. The data from each experiment was plotted in Graphpad Prism 6 and a one-phase decay curve was extrapolated from the data with 1000 iterations per time point. From the curve the half time (t 1/2 ) and the plateau (mobile/immobile fraction) was calculated. A Fisher's test was performed to identify significant differences.
GST-TDP-43 protein purification N-terminally tagged GST-TDP-43-WT was overexpressed in BL21(DE3)RIL E. coli. The E.coli cells were then lysed by sonication on ice in 40 mM HEPES (pH 7.4), 5 mM EDTA, 300 mM KCl, 1 mM DTT, 5% glycerol, 5 mM pepstatin, 10mg/l RNase A and protease inhibitors (cOmplete, EDTA-free, Roche Applied Science). The protein was purified over Glutathione Sepharose 4 Fast Flow beads (GE Healthcare) and eluted from the beads using 40 mM HEPES (pH 7.4), 150 mM NaCl, 5% glycerol, and 20 mM reduced glutathione.
PAR polymer
Free PAR polymer (commercially obtained from TREVIGEN) was synthesized from PARP-1 and ranged in size from 2-300 ADP-ribose subunits. Molar equivalencies were calculated by TREVIGEN, briefly, the Absorbance of the PAR at 258 nm was divided by the extinction coefficient of ADP-ribose (13, 500 cm -1 M -1 ) (Schultheisz et al., 2009; Shah et al., 1995) .
PAR-binding dot blot assay PAR-binding motifs were identified by aligning the PBM consensus to TDP-43 using the PATTINPROT search engine (Combet et al., 2000) . For dot-blot analysis of recombinant protein, 0.25-0.5 mg of protein, diluted in 40 mM hepes (pH 7.4), 150 mM NaCl, 5% glycerol and 20 mM reduced glutathione, was blotted onto 0.45 micron nitrocellulose membrane. Peptides, synthesized by GenScript (details are in the Key Resources Table and Figure 2), were spotted onto 0.1 micron nitrocellulose at 0.25-0.5 mg. Membranes were left to dry for 60-90 mins and then incubated in dPBS supplemented with 0.05% TWEEN20 (PBST) for 30 mins without agitation. The membrane was sealed in a hybridization bag (KPL) containing 0.4 mL of PBST containing 50nM PAR polymer (Trevigen) and incubated for 1 hr with rocking and rotation at room temperature. The membrane was washed 5 times in PBST (5 mins each) and blocked in PBSMT (5% milk in PBST) for 1 hr then incubated in primary antibody in PBST for 1 hr. After 5 washes in PBSMT (5 min each), the membrane was incubated with secondary antibody in PBSMT for 30 min. The membrane was washed 3 times in PBSMT, 2 times in PBST and 2 times in PBS (all 5 min each). ECL prime was used to detect secondary antibody. Antibodies used were anti-PAR (10H) (1 in 250; Tulip Biolabs and 1 in 500; ENZO) anti-TDP-43 (1 in 3000; Proteintech). HRP-coupled secondary antibodies used: goat antibody to rabbit (1 in 5,000; EMD Millipore) and goat antibody to mouse (1 in 2,000; Jackson ImmunoResearch Laboratories, Inc. and 1 in 5000; abcam). For SYPRO Ruby staining, blotted and dried membranes were submerged in PBS and then incubated in 7% acetic acid and 10% methanol for 15 minutes, the membrane was washed 4 times (5 mins each) in deionized H 2 O with gentle rotation, the membrane was incubated in SYPRO Ruby blot stain (ThermoFisher Scientific) for 30 min in the dark, washed 4 times in deionized H 2 O (5 mins each) and imaged on a Safe Imager (ThermoFisher Scientific). The dot blot was carried out 6 independent times and in addition was repeated on independent preparation of proteins. Spot intensities were measured using ImageJ software (Rueden et al., 2017) and statistics were performed using Graphpad prism 6 software.
Purification of Recombinant His 6 -SUMO-TDP-43
His 6 -SUMO N-terminally tagged TDP-43-WT was overexpressed in BL21(DE3)RIL E. coli. The E.coli cells were then lysed by sonication on ice in 50 mM HEPES (pH 7.5), 2% Triton X-100, 500 mM NaCl, 30 mM imidazole, 5% glycerol, 2 mM b-mercaptoethanol, and protease inhibitors (cOmplete, EDTA-free, Roche). The protein was purified over Ni-NTA agarose beads (QIAGEN) and eluted from the beads using 50 mM HEPES (pH 7.5), 500 mM NaCl, 300 mM imidazole, 5% glycerol, and 5 mM DTT. The protein was subsequently buffer exchanged into 50 mM HEPES (pH 7.5), 500 mM NaCl, 5% glycerol, and 5 mM DTT, flash frozen in liquid N 2 , and stored as aliquots in À80 C until use. His 6 -SUMO N-terminally tagged TDP-43-DPBM and TDP-43-Q331K were purified using the protocol described above. Note: for C35 and C25, the expression was induced with 1 mM IPTG for 2 hours at 37 C whereas for all the other proteins it was with 1 mM IPTG for 16 hours at 15 C. Purified His 6 SUMO-TDP-43 was thawed and centrifuged at 16,100 X g for 10 min at 4 C to remove preformed aggregates. Protein concentration was determined by Bradford assay (Bio-Rad). The purity of the expressed proteins was confirmed on a 4%-20% polyacrylamide gel.
Purification of Recombinant TDP-43-MBP-His 6
The plasmid encoding TDP-43-MBP-His 6 was purchased from addgene (plasmid #104480) and expressed in BL21 (DE3) RIL E. coli. following the conditions reported previously (Wang et al., 2018) . Cells were harvested by centrifugation, resuspended in TDP-43 binding buffer (20 mM Tris-Cl pH 8.0, 1 M NaCl, 10 mM imidazole, 10% (v/v) glycerol, 1 mM DTT) supplemented with cOmplete EDTA-free protease inhibitor cocktail, and lysed using an Emulciflex C-3. The protein was purified over Ni-NTA agarose beads (QIAGEN) and eluted from the beads using 20 mM Tris-Cl pH 8.0, 1 M NaCl, 300 mM imidazole, 10% (v/v) glycerol, 1 mM DTT. The eluate was further purified over amylose resin (NEB) and eluted from the amylose resin using 20 mM Tris-Cl pH 8.0, 1 M NaCl, 10mM maltose, 10% (v/v) glycerol, 1 mM DTT. The protein was concentrated, flash frozen in liquid N 2 , and stored as aliquots in À80 C until use.
Liquid-droplet formation
His 6 -SUMO-TDP-43 was prepared in 50 mM HEPES-NaOH (pH 7.5), 5% (v/v) glycerol, 5 mM DTT, and 100 mg/mL dextran from Leuconostoc spp. (Sigma, St. Louis, MO) with the indicated concentrations of NaCl. For TDP-43-MBP-His 6 , the protein was first buffer exchanged into 20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT and reactions were prepared in 20 mM HEPES, pH7.4, 1 mM DTT, 100 mg/mL dextran from Leuconostoc spp. (Sigma, St. Louis, MO) with the appropriate concentration of NaCl. Protein was always added last to each LLPS reaction. Protein samples were spotted onto a coverslip and imaged by differential interference contrast (DIC) microscopy. All movies and images were captured within ten minutes of reaction set-up. Details of experimental repeats are in the associated legends.
To assess the effect of PAR on TDP-43 phase separation, SUMO-TDP-43 was prepared as before but with the addition of 5 microM mono-ADP-ribose equivalents of PAR (Trevigen) or equivalent volume of PAR control buffer (10 mM Tris, pH8 and 1mM EDTA). For SUMO-TDP-43 and PAR experiments, all movies and images were captured within ten min of reaction set up. For TDP-43-MBP-His 6 with PAR or PAR control buffer, reactions were incubated at room temperature ($19 À22 C) for 1 hr prior to imaging. The PAR nucleation studies of TDP-43 LLPS were repeated twice at the phase boundary. The comparison between full-length TDP-43 and TDP-43 with mutation in the PAR-binding motifs has been tested three times on two or more different protein preps. The comparison between full-length TDP-43 and the C-terminal fragments has been repeated on two independent protein preps. Testing the effect of PAR on the TDP-43-WT, TDP-43-DPBM and the two C-terminal fragments has been repeated on two independent protein preps. Experiments examining the phase boundary of TDP-43-MBP were performed 3-5 times and experiments analyzing PAR nucleation three times using one protein prep. Further details are in each associated legend.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data points in each graph are mean (± SEM) and the n is a biological repeat. T Tests, one-way ANOVA, two-way ANOVA and multiple comparison tests were performed, and are described in each figure legend. Significance was set at p < 0.05. All statistical analyses were carried out using Graphpad prism6 software.
DATA AND SOFTWARE AVAILIBILITY
Raw datasets are available in Mendeley Data and are available at https://data.mendeley.com/datasets/rh7zv7w8c8/1. (A) Upon treatment with 0.5 mM sodium arsenite (1 hr), TDP-43-WT-YFP and TDP-43-DPBM-YFP formed cytoplasmic foci. TDP-43-WT was localized to stress granules whereas TDP-43-DPBM formed foci that were excluded from stress granules. Cells were immunostained with antibodies directed to Ataxin-2, G3BP1 and eIF3h. Cells were counterstained with Hoescht. Scale bars: 20 µm.
(B) Cells with both foci of TDP-43 and stress granules were quantified for colocalization. One coverslip was examined per condition. At least 300 stress granules from 5 non-overlapping images at 40X magnification were quantified from each condition. Graph represents the mean (± SEM) of 5 images per condition. (C) In rat cortical neurons, TDP-43-WT-GFP is nuclear, whereas TDP-43-DPBM-GFP is cytoplasmic. In rat cortical neurons, stress-induced foci of TDP-43-WT-GFP localized to TIAR-labelled stress granules, whereas stress-induced foci of TDP-43-DPBM-GFP were excluded from TIAR-labelled stress granules. Neurons were exposed to 0.5 mM sodium arsenite for 90 min, immunolabelled with TIAR and counterstained with Hoescht.
(D) Rat cortical neurons with both TIAR-labelled stress granules and cytoplasmic foci of TDP-43 were quantified for colocalization. The mean (± SEM) calculated from three independent experiments is presented. An unpaired and two-tailed T test was performed (p < 0.0001).
(E) Upon treatment with heat shock (43 o C for 30 min) TDP-43-WT-GFP localized to stress granules whereas TDP-43-DPBM-GFP formed foci that were largely excluded from stress granules. Cells were immunostained with an antibody directed to G3BP1 and counterstained with Hoescht.
(F) G3BP1-labelled stress granules were quantified for co-labelling with TDP-43-GFP. A mean (± SEM) from four independent experiments is presented. An unpaired and two tailed T-test was used to test for significance. Figure S5 (Related to Figure 6 ): Exclusion from stress granules leads to phosphorylation of TDP-43 foci that fail to resolve after the removal of stress.
(A) Stress-induced foci of TDP43-WT-YFP recruited to TIAR-labelled stress granules were not colabelled with pS409/10. Stress-induced foci of TDP-43-DPBM-YFP excluded from TIAR-labelled stress granules were co-labelled with pS409/10. Cells were immunolabelled with TIAR and pS409/10, counterstained with Hoescht and imaged by confocal microscopy. N: nucleus and hatched line is the nuclear/cytoplasm boundary. (C) Cells were quantified for the presence of Tankyrase-1/2 labelling of Ataxin-2 and TIAR labelled stress granules. Cells with one or more Tankyrase-1/2 containing stress granules were counted. The graph represents the mean (± SEM) of three independent experiments.
(D) Ataxin-2 and TIAR-labelled stress granules were quantified for the presence of Tankyrase-1/2 labeling of stress granules. The graph represents the mean (± SEM) of three independent experiments (E) Cells expressing TDP-43-WT-GFP were either left untreated or treated with 0.5 mM sodium arsenite (30 min) either in the absence of or presence of the Tankyrase-1/2 inhibitor (IWR-1-endo). Cells were pretreated with the indicated amount of inhibitor for 30 min prior to stress. Cells were immunostained for G3BP1 and counterstained with Hoescht. Arrows indicate cells with cytoplasmic TDP-43-WT-GFP foci. Ctrl: control.
(F) Cells were quantified for the presence of G3BP1-labeleld stress granules. The graph represents the mean (± SEM) from two independent experiments, a one-way ANOVA (p < 0.0001) and Tukey's test was used to test for significance. NS: not significant.
(G) Cells were quantified for the presence of cytoplasmic TDP-43-GFP foci. The mean (± SEM) from three independent experiments is presented. A one-way ANOVA (p <0.0001) followed by Tukey's test was used to test for significance. Asterisks: significant pairs.
